American Journal of Cardiology
Volume 102, Issue 9 , Pages 1119-1124, 1 November 2008

Relation Between Previous Lipid-Lowering Therapy and Infarct Size (Creatine Kinase-MB Level) in Patients Presenting With Acute Myocardial Infarction

  • Herbert D. Aronow, MD, MPH

      Affiliations

    • Clinical Scholars Program, Michigan Heart and Vascular Institute at St. Joseph Mercy Hospital, Ann Arbor, Michigan
    • Corresponding Author InformationCorresponding author: Tel: 734-712-8000; Fax: 734-712-8010
    • ,
  • A. Michael Lincoff, MD

      Affiliations

    • Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Martin J. Quinn, MD, PhD

      Affiliations

    • St. Vincents University Hospital, Dublin, Ireland
    • ,
  • A. Thomas McRae, MD

      Affiliations

    • Centennial Heart Cardiovascular Consultants, Nashville, Tennessee
    • ,
  • Hitinder S. Gurm, MD

      Affiliations

    • Division of Cardiovascular Medicine, University of Michigan Medical School, Ann Arbor, Michigan
    • ,
  • Penny L. Houghtaling, MS

      Affiliations

    • Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Christopher B. Granger, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Robert A. Harrington, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Franz Van de Werf, MD, PhD

      Affiliations

    • Department of Cardiology, University Hospital Gasthuisberg, Leuven, Belgium
    • ,
  • Eric J. Topol, MD

      Affiliations

    • Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California
    • ,
  • Michael S. Lauer, MD

      Affiliations

    • Division of Prevention and Population Sciences, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • GUSTO IIb and PURSUIT Trial Investigators

Received 27 February 2008; received in revised form 17 June 2008; accepted 17 June 2008. published online 29 August 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) was supported by COR Therapeutics, Inc., San Francisco, California, and Schering-Plough Research Institute, Kenilworth, New Jersey; and Global Use of Streptokinase or t-PA for Occluded Coronary Arteries IIb (GUSTO IIb) was supported by Ciba-Geigy, Inc., Summit, New Jersey; Boehringer-Mannheim, Indianapolis, Indiana; and Guidant Corp., Redwood City, California.

PII: S0002-9149(08)01134-X

doi:10.1016/j.amjcard.2008.06.032

American Journal of Cardiology
Volume 102, Issue 9 , Pages 1119-1124, 1 November 2008

Article Tools

* Image Usage & Resolution